Manufacturer record
Trugen Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Trugen Pharmaceuticals Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between January 2020 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TT 251884, Atenolol Tablets IP 50 MG, (exp Oct 2027). DTL Thiruvananthapuram (state lab) found it not of standard quality: Sample fails the test Dissolution as per IP, as specified in the Laboratory Protocol. Listed in the February 2026 alert.
Records by type
11 records linked to Trugen Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Atenolol Tablets IP 50 MG, | Batch TT 251884Mfg Nov 2025 · Exp Oct 2027 | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Feb 2026 |
| Diclofenac Sodium and Paracetamol Tablets IP | Batch TT240758Mfg Jun 2024 · Exp May 2026 | Dissolution Of ParacetamolDissolution | Government of NCT of DelhiState lab | Sep 2025 |
| Telmisartan Tablets IP 40 mg (Telwin-40 Tablets) | Batch TT230416Mfg Mar 2023 · Exp Feb 2025 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jun 2023 |
| Glimepiride Tablets IP 1 mg | Batch T22051Mfg Feb 2022 · Exp Jan 2024 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Feb 2023 |
| Glimepiride Tablets IP 1 mg | Batch T22060Mfg Mar 2022 · Exp Feb 2024 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Feb 2023 |
| Enalapril Maleate Tablets I.P. 5 mg | Batch T22093Mfg May 2022 · Exp Apr 2024 | Dissolution and AssayAssay | CDL KolkataCDSCO lab | Oct 2022 |
| Pregabalin Capsules IP 75 mg | Batch T21003Mfg Jan 2021 · Exp Dec 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2021 |
| Pregabalin Capsules IP 75 mg | Batch T20056Mfg May 2020 · Exp Apr 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2021 |
| Glimepiride Tablets IP 1 mg | Batch T20053Mfg May 2020 · Exp Apr 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2021 |
| Folic Acid Tablets IP 5 mg | Batch T20072Mfg Jul 2020 · Exp Jun 2022 | Description & Hydrolysis ProductsDescription | CDL KolkataCDSCO lab | Jul 2021 |
| Olmemark-40 (Olmesartan Medoxomil Tablet IP 40 mg) | Batch TPT8689Mfg Jun 2018 · Exp May 2020 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Jan 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.